Safety and Tolerability of Tirbanibulin 1% Treatment of Actinic Keratosis on Face and Scalp in Routine Clinical Practice Across the U.S. (PROAK Study). J of Skin. 2023;7(6):s263. doi:10.25251/skin.7.supp.263